Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Medicines | Support | Patient+ | Guidelines | Weblinks | News | Products | Other
Print options:   Other options:   Bookmark and Share

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

  • This is a dopamine agonist used for the management of motor symptoms of Parkinson's disease (PD).1
  • It has several different characteristics which mark it out from the rest of the dopamine agonist group used in the management of PD.
  • It is given subcutaneously.
  • It is structurally similar to dopamine and its use results in a rapid improvement in motor symptoms of PD by stimulation of dopaminergic receptors in substantia nigra.
Indications2,3
  • It is suitable for patients with advanced disease which is difficult to manage with levodopa. Age and disease duration does not affect efficacy.
  • As a rescue agent to provide rapid but short-lived benefit for sudden, severe 'Off' episodes, to establish whether further benefit can be obtained by increasing the dose of oral agents.
  • In patients unable to take oral medication due to acute illness or chronic dysphagia.
  • In cases of diagnostic difficulty.
Cautions, contra-indications2,4
  • The population in whom apomorphine can to most good is ironically the same in whom it can potentially do most harm i.e. elderly patients, who often have multisystem disease. However, a multicentre trial of 82 patients with a mean age of 67 years found a significant reduction in 'off' periods and severity of dyskinesia.5
  • It is specifically contraindicated in neuropsychiatric conditions, dementia, or if 'On' response to levodopa is marred by severe dyskinesia, hypotonia or psychiatric effects.
  • Monitoring for hepatic, renal, cardiovascular complications and haemolytic anaemia is required.

See Summary of Product Characteristics for full list.1

Adverse effects2,4

Mainly nausea, vomiting and postural hypotension.

Main Interactions

Apomorphine is antagonised by antipsychotics and methyldopa; it is enhanced by entacapone and memantine. See drug monograph for full list.

The Apomorphine Challenge Test. 2

WARNING: The onset of postural hypotension in patients challenged with apomorphine can be severe and unpredictable. It should only be attempted in clinical setting where such emergency can be dealt with i.e. access to full resuscitative facilities and expertise.

Purpose

To check:

  • Whether the patient responds to the medication.
  • Optimal dose (efficacy vs adverse effects).
  • Educate patient/carers in delivery method.
  • Assess whether patient likely to respond to further dopaminergic stimulation if already on oral medication - the decision may then be to either commence therapy to increase oral medication rather than start apomorphine.

Protocol

  • Prescribe domperidone 20mg t.d.s. to be started 3 days prior to challenge.
  • Perform a routine ECG to rule out cardiac disease.
  • Provide information and obtain informed consent.
  • Advise the patient to have an early light breakfast, as the test can take several hours.
  • The patient needs to be in the 'Off' phase, so morning medication is usually omitted. This may vary depending on mobility needs of patient.
  • Perform challenge first thing in morning to minimise patient discomfort.
  • Perform a baseline motor examination using the Unified Parkinson's Disease Rating Scale (UPDRS).6 Time a 6 or 12 m walk.
  • Administer single increasing subcutaneous doses of apomorphine (e.g.1.5 mg, 3 mg, 4.5 mg, 6 mg, 7 mg) at 45 minute to one hour intervals until a response is seen. If there is a mild response at 7 mg, some clinics use 10 mg.
  • Recheck motor assessment 20 minutes after each dose using UPDRS e.g. walking, time in seconds required to tap index finger right or left hand 20 times between 2 points placed 12 inches apart.

Interpretation of Results and Further Action

A challenge is positive if there is:

  • A decrease in the UPDRS motor score by at least 20%
  • At least a 20% improvement in either timed hand tests or timed walking

If there is a positive challenge, consider whether to increase levodopa dose (as test proves that condition is responsive to dopaminergic stimulation) or to institute apomorphine.

Methods of delivery7,8,9,10
  • Intermittent Subcutaneous Injections
    • These are used as rescue therapy for disabling 'Off' periods in patients taking oral therapy.11
    • The 'Off' period can be averted or reversed within 10-15 minutes and can last for up to one hour.
    • They are suitable for patients who have short 'Off' periods less than six times a day. For more frequent episodes, continuous infusion should be considered.
    • Injections need to be given no later than the beginning of the 'Off' period.
    • Most patients can be taught to self-administer. Injection should be to lower abdominal wall below umbilicus, upper outer aspect thighs or outer aspect top of arms.
    • Patients should be advised to rotate the injection site and gently massage after administration, to avoid nodule formation.
    There are two ways to administer apomorphine. Choice governed by patient preference, condition and cost.
    • Pre-filled penject device (APO-go Pen®) - 30 mg in 3 ml, needs to be discarded every 48 hours but needle needs changing after each injection
    • Insulin-type syringe - patient prepares syringe using 2 ml (10 mg/ml) amp apomorphine, prepared on daily basis, discard unused syringe after 24 hours.
  • Continuous Infusion
    • Indicated for patients with advanced disease who experience frequent unpredictable and disabling motor fluctuations and dyskinesias despite maximal oral therapy
    • Can be given as adjunct or monotherapy
    • Benefits comparable to deep brain stimulation of subthalamic nucleus
    • Most patients only need infusion during waking hours, a few need 24 hour therapy
    • Mean daily dosage range 50-100 mg per day
    • Initiation requires hospital admission to educate patient and monitor for side effects
    • Titration in community required, may take several months to obtain optimal dose and response
    • Used to be administered only by Sims-Graseby syringe driver
    • APO-go pump now available
    • Choice depends on patient preference and cost


Document references
  1. Summary of Product Characteristics - APO-go® PFS 5mg/ml Solution for Infusion in Pre-filled Syringe (apomorphine) Britannia Pharmaceuticals Limited updated May 2008; accessed July 2008; electronic Medicines Compendium.
  2. Sharma JC, Macnamara L, Hasoon M, et al; Diagnostic and therapeutic value of apomorphine in Parkinsonian patients. Int J Clin Pract. 2004 Nov;58(11):1028-32. [abstract]
  3. Cotzias GC, Papavasiliou PS, Tolosa ES, et al; Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. N Engl J Med. 1976 Mar 11;294(11):567-72. [abstract]
  4. Colzi A, Turner K, Lees AJ; Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. [abstract]
  5. Garcia Ruiz PJ, Sesar Ignacio A, Ares Pensado B, et al; Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study. Mov Disord. 2008 Apr 28;23(8):1130-1136. [abstract]
  6. Unified Parkinson's Disease Rating Scale; MD Virtual University
  7. Kempster PA, Frankel JP, Stern GM, et al; Comparison of motor response to apomorphine and levodopa in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):1004-7. [abstract]
  8. Swinn LA, James CR, Quinn NP et al; Shared Care Guidelines 2005: Treatment of Parkinson's Disease with Apomorphine.
  9. Esteban Munoz J, Marti MJ, Marin C, et al; Long-term treatment with intermitent intranasal or subcutaneous apormorphine in patients with levodopa-related motor fluctuations. Clin Neuropharmacol. 1997 Jun;20(3):245-52. [abstract]
  10. Katzenschlager R, Hughes A, Evans A, et al; Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord. 2005 Feb;20(2):151-7. [abstract]
  11. Stacy M, Silver D; Apomorphine for the acute treatment of "off" episodes in Parkinson's disease. Parkinsonism Relat Disord. 2008;14(2):85-92. Epub 2007 Dec 21. [abstract]

Internet and further reading AcknowledgementsEMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 277
Document Version: 4
DocRef: bgp26035
Last Updated: 18 Jul 2008
Review Date: 18 Jul 2009

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.

Patient UK Hearing Impairment Survey

Patient UK are grateful to the 550 people who took part in this survey.
To see the results click here.
If you'd like to leave your feedback, please go to our interactive forum.

Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Medicines | Support | Patient+ | Guidelines | Weblinks | News | Products | Other
Print options:   Other options:   Bookmark and Share
Want to search some more? Use the Google Search box below to search our site.

Related pages in Patient UK

Your Experience (^ top of page)

 Please add your experience about this condition / medicine
 Parkinson's Disease

 Apomorphine

Support Group European Parkinson's Disease Association
Support Group Parkinson's Disease Society
Support Group YPN - Younger Parkinsons Network

 Catechol-O-Methyltransferase (COMT) Inhibitors
 Parkinsonism and Parkinson's Disease
 Parkinson's Disease Management
 Recurrent Falls

 Guidelines on Parkinson's Disease

 Parkinson's Disease

Recent related news items

 Can drugs for Parkinson's Disease cause uncontrollable desires?
 Gout chemical 'may help' Parkinon's
 Gout chemical slows Parkinson's
 Making people move in slow motion
 Scandal of Parkinson's sufferers forced to foot bill for own care

All news by related topic

 Parkinson's Disease news

Medical equipment

 Bathroom Aids
 Bedroom Aids
 Daily Living Aids
 Kitchen Aids
 Pill/Tablet Equipment

Visit the Patient UK Medical Equipment shop

Books

 Parkinson's Disease (The Daily Telegraph)
 Parkinson's Disease (Understanding).
 Parkinson's Disease : British Medical Association's Family Doctor Series
 Parkinson's Disease Handbook (the)
 Parkinson's Disease: A Guide to Treatments, Therapies and Controlling Symptoms (Daily Telegraph)
 Parkinson's: A Patient's View
 Parkinson's: Answers At Your Fingertips (3rd Edition)

Visit the Patient UK shop

Other - Useful resources (^ top of page)

Pictures, diagrams, photos, images, etc.
Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites

Want to search some more? Use the Google Search box below to search our site.

Advertisements











Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Click here to return to the home page
Click here to read our 'About Us' page
Go to the Emis Access website, where you can book an appointment with your GP, order a repeat prescription or view you medical record online.
Note: this will open in a new window
View and/or join in discussion about health, lifestyle and disease in our interactive forum.
Note: this will open in a new window
Go to our pharmacy product price comparison pages.
Go to our online newspaper for current medical news and commentary.
Note: this will open in a new window
Adverts on this site do not influence the medical content. Click to read more.
Adverts on this site do not influence the medical content. Click to read more.